Waters Corporation (WAT)

Currency in USD
396.71
+12.85(+3.35%)
Closed·
394.80-1.91(-0.48%)
·
WAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
383.01399.56
52 wk Range
275.05423.56
Key Statistics
Prev. Close
396.71
Open
385.77
Day's Range
383.01-399.56
52 wk Range
275.05-423.56
Volume
518.95K
Average Volume (3m)
561.32K
1-Year Change
-2.8505%
Book Value / Share
39.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
410.01
Upside
+3.35%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Waters Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation SWOT Analysis


Biologics Boost
Waters Corporation strategically positions itself in the rapidly expanding biologics market, with acquisitions and product developments strengthening its offerings in this high-growth sector.
Financial Health
Explore Waters' robust financial metrics, including a 59.3% gross profit margin and nearly $3 billion in annual revenue, underpinning its strategic initiatives and market expansion.
Market Dynamics
Delve into the projected 10.3% CAGR of the biologics market through 2028, and how Waters' specialized expertise in QA/QC for biopharmaceuticals positions it for potential outperformance.
Analyst Outlook
Analyst price targets range from $360 to $460, reflecting varied perspectives on Waters' growth potential amid its focus on high-growth areas like GLP-1 treatments and biologics.
Read full SWOT analysis

Waters Corporation Earnings Call Summary for Q3/2025

  • Waters Corporation exceeded Q3 2025 expectations with EPS of $3.40 vs. $3.21 forecast and revenue of $800M vs. $781M forecast, driving a 4.46% stock increase.
  • Revenue grew 8% year-over-year with particularly strong performance in the pharmaceutical sector (11% increase), maintaining healthy 59% gross and 30.3% operating margins.
  • The company raised its full-year 2025 guidance, projecting 6.7-7.3% constant currency sales growth and adjusted EPS of $13.05-$13.15, representing double-digit growth.
  • Waters is preparing for a strategic business combination with BD Biosciences expected in Q1 2026, which management anticipates will drive further value creation.
  • CEO Udit Batra emphasized that their growth strategy is 'delivering exceptional performance,' while CFO Amol Chaubal highlighted the company's resilience in facing challenges.
Last Updated: 04/11/2025, 14:28
Read Full Transcript

Compare WAT to Peers and Sector

Metrics to compare
WAT
Peers
Sector
Relationship
P/E Ratio
36.4x29.8x−0.6x
PEG Ratio
9.541.500.00
Price/Book
10.1x3.9x2.6x
Price / LTM Sales
7.6x2.4x3.4x
Upside (Analyst Target)
2.1%7.6%42.5%
Fair Value Upside
Unlock2.4%5.8%Unlock

Analyst Ratings

8 Buy
10 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 410.01
(+3.35% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy440.00+10.91%-New Coverage06/01/2026
William Blair
Buy---New Coverage05/01/2026
Wells Fargo
Hold415.00+4.61%385.00Maintain15/12/2025
Wolfe Research
Buy480.00+21.00%-Upgrade10/12/2025
Morgan Stanley
Hold423.00+6.63%-New Coverage02/12/2025

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
3.40 / 3.21
Revenue / Forecast
800.00M / 781.01M
EPS Revisions
Last 90 days

Waters (WAT) Income Statement & Profits

People Also Watch

78.58
OMC
+0.70%
259.28
RMD
+2.41%
208.47
CAH
-0.90%
45.26
CNC
-1.09%
274.91
CI
+1.35%

FAQ

What Is the Waters (WAT) Share Price Today?

The live Waters share price today is 396.71

What Stock Exchange Does Waters (WAT) Trade On?

Waters is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Waters?

The stock symbol (also called a 'ticker') for Waters is "WAT."

What Is the Current Waters Market Cap?

As of today, Waters market capitalisation is 23.62B.

What Is Waters's (WAT) Earnings Per Share (TTM)?

The Waters EPS is currently 10.88 (Trailing Twelve Months).

When Is the Next Waters Earnings Date?

Waters's next earnings report will be released on 12 Feb 2026.

Is WAT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Waters moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Waters Stock Split?

Waters has split 2 times. (See the WAT stock split history page for full effective split date and price information.)

How Many Employees Does Waters Have?

Waters has 7600 employees.

What is the current trading status of Waters (WAT)?

As of 22 Jan 2026, Waters (WAT) is trading at a price of 396.71, with a previous close of 396.71. The stock has fluctuated within a day range of 383.01 to 399.56, while its 52-week range spans from 275.05 to 423.56.

What Is Waters (WAT) Price Target According to Analysts?

The average 12-month price target for Waters is USD410.01, with a high estimate of USD480 and a low estimate of USD348.15. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.